Cash and cash equivalents were $119.2 million as of March 31, 2024.
Vistagen Reports FY24 Net Loss Of $(29.4)M Vs $(59.2)M Last Year
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.